Jonathan Edelman, senior vice president of CSL’s vaccines innovation unit, said the approval “marks a significant milestone” ...
The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...
BTIG raised the firm’s price target on Arcturus Therapeutics (ARCT) to $48 from $41 and keeps a Buy rating on the shares. The Kostaive ...
AeroVironment has launched a new variant of its Jump 20 vertical take-off and landing (VTOL) uncrewed aircraft system, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results